[1]田嘉禾.关于放射免疫治疗的新思考[J].国际放射医学核医学杂志,1997,21(5):249-252.
点击复制

关于放射免疫治疗的新思考(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
21
期数:
1997年第5期
页码:
249-252
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

作者:
田嘉禾
中国人民解放军总医院核医学科, 北京 100853
关键词:
放射免疫治疗肿瘤单克隆抗体生物学效应
摘要:
尽管过去十多年间放射免疫治疗(RIT)对实体性肿瘤的临床和实验结果不理想,近年来新的方法和认识可能对RIT的应用有进一步的促进。RIT的改进主要体现在以微小病灶为主,多次给药,与其他技术配合,免疫调节,以及从肿瘤、机体的生物学特征和放射生物学角度进行T/NT比、McAb瘤内存留时间、细胞学因素、放射剂量的空间与时间分布及肿瘤微环境和宿主体内因素利用等方面的改善和重视。RIT的生命力体现在上述方面的新的认识。

参考文献/References:

1 Zanzonico P. J Nucl Med,1992;33:2180-2183
2 Delalye AB et al. Eur J Nucl Med,1995;22:571-580
3 Langmuir VK et al. Med Phys,1993;20:601-610
4 Dale RG. Phys Med Biol,1996;41:1871-1884
5 Rao DV et al. J Nucl Med,1993;34:1801-1810
6 Blumenthal RD et al. Sel Cancer Ther,1991;7:9-16
7 Buchegger F et al. Cancer Res,1995;55:83-89
8 Wilder RB et al. Int J Radiat Oncol Biol Phys,1994;28:119-126
9 Roffler SR et al. Cancer Res,1994;54:1276-1285
10 Greiner JW et al. Antican Res,1996;16:2129-2134
11 Leigh BR et al. Radiat Res,1995;142:12-15
12 Takahashi H et al. Neurol Med,1993;33:610-615
13 Buchsbaum DJ et al. Cancer(suppl),1994;73:999-1005
14 Buchsbaum DJ. Cancer Res(suppl),1995;55:5729s-5732s
15 Sgouros G. J Nucl Med,1992;33:2167-2179
16 Tian JH et al. J Nucl Med,1996;37:958-963
17 Knox SJ et al. Radiat Res,1993;135:24-31
18 Williams JR et al. Int J Radiat Oncol Biol Phys,1992;24:699-704
19 Oettgen HF. Immunology,1991;3:699-705

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
 He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
 Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
 Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
 Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
 zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
 Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
 Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
 Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
 Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[10]王浩,周则卫,周晓靓.N-(5-硝基吲唑-3-甲酰)酪氨酸钠的制备、乏氧增敏与体内分布研究[J].国际放射医学核医学杂志,2015,39(3):235.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]
 Wang Hao,Zhou Zewei,Zhou Xiaoliang.Synthesis, hypoxic radiosensitization and biodistribution of N-(5-nitroindazole-3-formyl) tyrosine sodium[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):235.[doi:10.3760/cma.j.issn.1673-4114.2015.03.010]
[11]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
 Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[12]张弘.用于放免治疗的核素研究进展[J].国际放射医学核医学杂志,2003,27(4):148.
 ZHANG Hong.Advances in radionuclide for radioimmunotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):148.
[13]杨连君,司晓辉,隋延仿,等.90Y标记单克隆抗体导向治疗肿瘤[J].国际放射医学核医学杂志,1996,20(5):205.

备注/Memo

备注/Memo:
收稿日期:1997-09-30。
更新日期/Last Update: 1900-01-01